AzTrials
AzTrials

ArthrofibrosisSTAKNCT04019847

STAK Tool for Treatment of Arthrofibrosis Post Total Knee Replacement

A study testing STAK Tool and Standard treatment in people with Arthrofibrosis, run by University Hospitals, Leicester at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A common complication following total knee replacement (TKR) is arthrofibrosis, a severe stiffening of the knee caused by scar tissue. The aims of this mixed methods feasibility study are to (1) record the effect of use of the STAK Tool on knee flexion active range of movement (KROM) immediately following 8 weeks use… Read more about this study

Who is it for?
Ages 18 to 95 yearsHealthy volunteers can take part
Conditions the study is for
Arthrofibrosis
What is being tested?
STAK Tool and Standard treatment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
35 participants
Where
1 siteUnited Kingdom
Study dates
2 Aug 2017to 19 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 95 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • male or female,
  • 18 to 95 year olds,
  • having received a primary total knee replacement within the last 12 months.
  • Following their TKR have less than 70 degrees knee flexion or have been prescribed intensive physiotherapy for their knee stiffness by their Consultant.
  • Between 44kg and 159kg.

Who cannot join

  • post malignancy or knee trauma
  • have leaking wounds or infected joints,
  • have rheumatoid arthritis or osteoporosis,
  • have undergone long term steroid treatment or the clinician felt the patient was at risk of post-operative fracture.
  • Fell outside weight limits (44kg to 159kg),
  • Unable to give consent themselves (confusion, non-English speaking patients).

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University Hospitals of Leicester NHS Trust

    Leicester, LE5 4PW

Other trials in United Kingdom

About this study

Official title: A Feasibility Study Considering the Use of the STAK Tool in Addition to Standard Physiotherapy Compared to Standard Physiotherapy Alone to Treat Arthrofibrosis Patients Following Total Knee Replacement

A common complication following total knee replacement (TKR) is arthrofibrosis, a severe stiffening of the knee caused by scar tissue.

The aims of this mixed methods feasibility study are to (1) record the effect of use of the STAK Tool on knee flexion active range of movement (KROM) immediately following 8 weeks use and 6 months following use, (2) explore patients' experiences of arthrofibrosis and use of the STAK Tool, (3) Consider appropriate outcome measures (e.g. KROM, patient experience/acceptability, The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Oxford Knee Score (OKS) and other clinical measures and (4) design a protocol to evaluate the effectiveness of the STAK Tool.

Read the detailed description

Arthrofibrosis most commonly occurs after total knee replacement (TKR), extensive intra-articular injury or surgical procedures, for example fracture of the proximal tibia or distal femur or multiple ligament reconstructions (Creighton and Bach 2012). Arthrofibrosis involves a severe stiffening of the knee caused by scar tissue. This often results in a lack of crucial range of knee flexion movement. Traditional physiotherapy treatment includes a home exercise programme involving regular intense stretches and mobilisations delivered by the physiotherapist at the hospital aiming to enable the patient to regain optimal, functional knee bend. The inflammatory process and remodeling of soft tissues following trauma can lead to production of scar tissue and subsequent stiffness. This results in increased pain and difficulty in performing exercises. This often limits progress requiring high numbers of physiotherapy sessions and potentially further surgery (manipulation under anaesthetic) to restore range of movement.

The STAK Tool enables the patient to perform intense self-stretching of the knee more easily and effectively. Intense stretching is essential to increase KROM (Bonutti et al 2008, Bonutti 2010, Papotto et al 2012, Stephenson et al 2010). Patients who fall into the category of having restricted KROM (less than 70 degrees flexion) and those whose Clinicians identify them as requiring further intensive physiotherapy to address their stiffness would be approached to take part in this study. 36 participants would be recruited. Participants would be over 18 years old, between 44kg and 159kg. This mixed methods feasibility study would investigate patients' progress and outcomes in overcoming arthrofibrosis using the STAK Tool a medical stretching device at home plus standard physiotherapy treatment (intervention group), compared to patients receiving physiotherapy treatment only (comparative group). Participants would be allocated into either the intervention or comparative group. Participants would be instructed to use the STAK Tool for 5-10 minute periods for a minimum total of 20 minutes and maximum of 60 minutes a day.

Participants would receive their standard physiotherapy treatment including KROM, full weight bearing exercises including sit to stands, squats, body weight assisted passive stretches, strengthening exercises and mobilisations. Angle of knee flexion would be measured (standardised method) by the Principal Investigator and the WOMAC and OKS are administered on the day the participant consents to the study (Visit 1), the day the intervention starts. This will be within approximately 2 weeks of the patient being identified by their clinician. (The Principal investigator will visit the participant within 10 days to ensure there are no problems using the STAK Tool (Visit 2 - only intervention group). During Visit 1 an interview (interview 1), would be conducted to explore the patients' initial thoughts on the STAK Tool after being introduced to it. Both the intervention and comparative groups will have their KROM recorded using two different measuring instruments, the universal goniometer and the Hudl Ubersense App. Outcome measures including KROM, WOMAC and OKS will be recorded again following approximately 8 weeks treatment (dependent on time available before manipulation as per normal clinical care), at either the patient's final follow-up with their Clinician or at their home (Visit 3) (end of intervention). The WOMAC and OKS would help to ascertain the patient's perceptions of pain, stiffness and functional improvements. At Visit 3 participants would also complete a questionnaire regarding the frequency of knee stretching exercise completed and how easy/difficult it had been to achieve. On completing 8 weeks standard treatment patients in the comparative group who were deemed eligibility by their Clinician would be offered the STAK Tool 8 week treatment.

Visits would then be completed as per the intervention group minus the interviews.

An in-depth semi-structured interview (interview 2) will be conducted with participants in the intervention group exploring their thoughts and experiences of using the STAK Tool to increase their knee flexion, their perceived progress and acceptability of the device.

A follow up meeting (Visit 4) would take place at 6 months after Visit 3, this would take place at the participant's home patients KROM, WOMAC and OKS would be recorded to provide data relating to participants long term outcomes.

Conditions
Arthrofibrosis
Being tested
STAK Tool, Standard treatment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • STAK ToolDevice

    Medical stretching device

  • Standard treatmentOther

    Physiotherapists tailor treatment of arthrofibrosis to meet their patients' individual needs. Treatment may comprise the following: education, advice and a range of stretching exercises/techniques to change the length and density of the adhesions and shortened tissue. These include active range of movement (AROM), passive range of movement (PROM), strengthening exercises, hands-on high intensity passive physiological stretches, joint mobilisations and a home exercise programme involving full weight bearing exercises with the aim of enabling the patient to regain AROM and function

Study groups in NCT04019847
Study groupRoleWhat they receive
STAK ToolExperimentalThe STAK Tool enables patients to apply a high intensity stretch to their knee independently. Patients are asked to do this for a maximum of 60 mins per day.
Receives: Device: STAK Tool; Other: Standard treatment
Standard treatmentActive comparatorPatients are treated as per their Clinician's prescription. Physiotherapists tailor treatment of arthrofibrosis to meet their patients' individual needs. Treatment may comprise the following: education, advice and a range of stretching exercises/techniques to change the length and density of the adhesions and shortened tissue. These include active range of movement (AROM), passive range of movement (PROM), strengthening exercises, hands-on high intensity passive physiological stretches, joint mobilisations and a home exercise programme involving full weight bearing exercises with the aim of enabling the patient to regain ROM and function.
Receives: Other: Standard treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in range of knee movement as assessed using a universal goniometer

    Universal goniometer used to measure knee range of movement

    Measured: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control

  2. Change in range of knee movement as assessed using a mobile app.

    A Mobile app used to measure knee range of movement

    Measured: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control

Secondary outcomes (2)
  1. WOMAC Score (The Western Ontario and McMaster Universities Osteoarthritis Index)

    Patient reported outcome measure relating to patient's pain, stiffness and function

    Measured: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control

  2. Oxford Knee Score (OKS)

    Patient reported outcome measure relating to pain and function, specifically designed for total knee replacement patients.

    Measured: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2019
  2. Study start2 Aug 2017
  3. Primary completion19 Aug 2019
  4. Study completion19 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Sequential
Masking
Single blind
Who is masked
Care provider
Enrolment
35 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04019847
Sponsor's protocol ID
93160
Acronym
STAK
Status last verified
Apr 2020
First submitted
11 Jun 2018
Last updated
28 Apr 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing STAK Tool and Standard treatment in people with Arthrofibrosis, run by University Hospitals, Leicester at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in range of knee movement as assessed using a universal goniometer (time frame: Baseline, 8 weeks after intervention/control, and 6 months after intervention/control). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in